Elsevier

Cryobiology

Volume 46, Issue 3, June 2003, Pages 238-245
Cryobiology

Antitumor effects of residual tumor after cryoablation: the combined effect of residual tumor and a protein-bound polysaccharide on multiple liver metastases in a murine model

https://doi.org/10.1016/S0011-2240(03)00039-7Get rights and content

Abstract

Cryoablation is a low-invasive surgical treatment for malignant tumors. It may induce an immunological response leading to the eradication of distant metastases or alternatively it might promote the growth of residual tumors. In this paper we confirm the occurrence of both phenomena and we describe the preventive effect of a protein-bound polysaccharide preparation. Metastatic liver tumors were produced in BALB/c mice by the intrasplenic inoculation of colon 26 cells and cryoablation was carried out using liquid nitrogen (−170 °C) applied by a contact method. The value of combining cryoablation with administration of the polysaccharide preparation in the prevention of growth of residual tumors was investigated. It was shown that the number of metastatic liver nodules and the size of the primary tumor at the site of inoculation in the spleen were significantly lower when the volume that was frozen was small. The production by splenocytes of the tumor necrosis factor TNF-α, interferon INF-γ, and the interleukins IL-4 and IL-10 increased significantly after freezing and thawing of the tumor tissue. The polysaccharide treatment significantly reduced the production of IL-4 and IL-10 following cryoablation; the production of TNF-α and INF-γ was slightly promoted; the natural killer and cytotoxic T-cell activities of splenocytes were slightly enhanced. It was concluded that the polysaccharide preparation was beneficial by suppressing IL-4 and IL-10 production and might inhibit the growth of residual tumor that is sometimes induced by large-volume cryoablation.

Introduction

The treatment of malignant tumors by cryoablation has attracted attention because of its low invasiveness and relatively low cost. Considerable therapeutic effects on metastatic liver tumors [2], [16] and prostatic cancer [6], [15] have been reported. Cryoablation may not only destroy tumor directly by freezing and thawing, but may also induce a specific anti-tumor effect by an immune mechanism that is stimulated by tumor antigens released by the cryonecrotic tissue [1], [18]. Thus, cryoablation may be particularly promising in the treatment of advanced cancer with distant metastasis. However, it was observed in Japan from the late 1970s that cryosurgical treatment of tumors could have the negative effect of enhancing the growth of residual tumors and the method became less popular [5], [21]. This phenomenon was named high-zone tolerance.

We considered the possibility that the tumor enhancement and reduced survival might be induced by sensitization caused by a large amount of frozen and thawed tissue. We studied a metastatic liver tumor model in mice that was produced by the intrasplenic inoculation of colon 26 cells into BALB/c mice and we reported the preventative effects of biological response modifiers such as the protein-bound polysaccharide preparation we have called Krestin [19]. In the present study, we investigated the anti-tumor effect of cryoablation by a contact method on metastatic liver tumors and we discuss the mechanism underlying tumor enhancement and the preventative effects of Krestin.

Section snippets

Experimental animals and tumor

Six-week-old male BALB/c mice and the mouse colon cancer cell line, colon 26 were used. There were five mice in each group.

Tumor inoculation

Under ether anesthesia the spleen was transposed to a subcutaneous pouch and a metastatic tumor was induced by injection of 1×105 colon 26 cells into the inferior border of the spleen.

Cryoablation against metastatic liver tumors

Fourteen days after inoculation of the tumor cells, laparotomy was performed by subcostal skin incision and mice having about six visible nodules over 1 mm in diameter were selected for the

Number of metastatic liver nodules

When mice were killed on day 14 after cryoablation, there was no gross evidence of tumor growth or of persistence around the frozen lesions, and slight scar formation was observed. The number of metastatic liver nodules in the SV group was significantly lower (13.2±1.3) than those in the control group (p<0.05) and the LV group (p<0.05).

The LV group showed the highest number, but there was no statistically significant difference between the LV group and the controls. On the other hand, in the

Discussion

We have previously studied immune responses following tumor cryoablation by examining morphological changes in regional lymph nodes [8] and the effects of serum obtained after cryoablation on rat lymphoblasts that had been induced by PHA [12] or Con A [13]. We observed that some types of tumor-specific anti-tumor immune response were enhanced in regional lymph node lymphocytes obtained after cryoablation when they were evaluated by measuring cytotoxic activity and/or lymphocyte subsets [10].

Conclusions

A BALB/c mouse model of metastatic liver cancer was produced by the intrasplenic inoculation of colon-26 cells. This model was used to examine the anti-tumor effect of cryoablation by the contact method and to compare its usefulness in combination with Krestin to prevent the high zone tolerance induced by massive freezing. The production of cytokines and NK or CTL activity of splenocytes were measured. The results suggest that Krestin improves the cytokine balance and shows an anti-tumor effect

References (21)

There are more references available in the full text version of this article.

Cited by (0)

This work was funded by institutional sources.

View full text